MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Comparison of Age, Cognitive, Autonomic, and Motor Testing between Serotonergic vs Idiopathic REM-Sleep Behavior Disorder

    M. Berns, N. Reddy, H. Olson, R. Berns, M. Howell (Minneapolis, USA)

    Objective: To compare the age, cognitive, autonomic, and motor function of REM-Sleep Behavior Disorder (RBD) patients amongst those who believe their symptoms were triggered by…
  • 2024 International Congress

    Speech features in Korean Parkinson’s disease patients: A prospective cohort study

    D. Yoo, S. Cho, J. Kim, J. Bang (Seoul, Republic of Korea)

    Objective: In this study, we explored speech characteristics of Korean Parkinson's disease (PD) patients and their usefulness as a biomarker. Background: Previous studies have shown…
  • 2024 International Congress

    Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

    E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

    Objective: To assess whether an app-based mindfulness training (MT) intervention, “Unwinding Anxiety”, can be used for Parkinson’s Disease (PD) patients with mild-moderate anxiety to reduce…
  • 2024 International Congress

    TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

    SJ. Song, YE. Kim (Anyang, Republic of Korea)

    Objective: Unveiling the Pain Mechanism in Parkinson's Disease: A Path to New Therapies Background: Parkinson's disease (PD) are well-known movement disorder. While motor symptoms are…
  • 2024 International Congress

    Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO), A Novel Retinal Mitochondrial Biomarker For Parkinson’s Disease

    K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

    Objective: Using fluorescence-lifetime ophthalmoscopy (FLIO), we identified retinal mitochondrial changes in Parkinson’s disease (PD) patients compared to controls. Background: FLIO, a novel non-invasive, in vivo…
  • 2024 International Congress

    When Off Can Cost Life: Myocardial Infarction Due to Spontaneous Coronary Dissection as a Catastrophic Manifestation in Advanced Parkinson’s Disease.

    S. Poveda, T. Lopez, B. Pascual Sedano, A. Campolongo (Bogotá, Colombia)

    Objective: Describe a patient with PD who suffered an acute myocardial infarction during a severe OFF period. Background: Advanced PD is characterized by complications including…
  • 2024 International Congress

    Prevalence and characteristics of anxiety in Parkinson’s disease

    I. Murasan, S. Diaconu, L. Ungureanu, I. Despa, A. Zarnoveanu, B. Opritoiu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To evaluate the characteristics of anxiety in relation to motor and non-motor symptoms in a cohort of PD patients. Background: Anxiety is a frequent…
  • 2024 International Congress

    The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry

    O. Odeniyi, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Lagos, Nigeria)

    Objective: To determine the relationship between non-motor symptom (NMS) burden and quality of life in persons living with Parkinson’s disease (PD) recruited into the registry.…
  • 2024 International Congress

    Prevalence of Non-Motor Symptoms in Patients with Parkinson Disease in a Tertiary Hospital in Santiago, Chile.

    M. Sánchez, V. Rosado, C. Montalva, P. Salles, J. Fuentes, P. Chaná (Santiago, Chile)

    Objective: Objective:Determine the prevalence of NMS in patients with Parkinson disease attending the Hospital San Juan de Dios Neurology Clinic. Background: Background:Parkinson disease (PD) is…
  • 2024 International Congress

    Evaluating the Impact of the Pain Self-Management Program in PD

    A. Zawar (Lynnwood, USA)

    Objective: The program aims to provide PD individuals with skill sets, knowledge, and tools necessary to effectively self-manage their pain through non-pharmacological approaches. By empowering…
  • « Previous Page
  • 1
  • …
  • 301
  • 302
  • 303
  • 304
  • 305
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley